Postoperative B-type natriuretic peptide monitoring for the assessment of the magnitude of shunting through Blalock-Taussig anastomoses

In MBTS patients without atrio-ventricular valve regurgitation, maintaining BNP below 1000 pg mL− 1 may represent a therapeutic target to avoid over-shunting.